BeiGene's datuximab beta injections and injectable zenidazumab entered the first edition of the commercial insurance innovative drug catalogue.

Zhitongcaijing · 2d ago
BeiGene's datuximab beta injections and injectable zenidazumab entered the first edition of the commercial insurance innovative drug catalogue.